Gufic Biosciences informs about outcome of board meeting

01 Aug 2020 Evaluate

Gufic Biosciences informed that the Board of Directors of the Company at its Meeting held on July 31, 2020, which commenced at 8:00 pm and concluded at 11.40 pm on July 31, 2020, considered and approved the following: The Audited Financial Results for the quarter and financial year ended March 31, 2020. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations'), enclosed is the said results together with the Auditors Report with unmodified opinion, recommended Dividend at 5% Re 0.05 per equity share (Face Value of Re. 1 each) for the financial year ended March 31, 2020, subject to the approval of the Shareholders at the ensuing Annual General Meeting, and approved the updated Code of Conduct for Prevention of Insider Trading in line with the amended provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The said Code of Conduct is updated on the website of the Company and is available for the stakeholders of the Company at www.gufic.com.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

347.40 -0.15 (-0.04%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×